Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes

Brain Research

Volumn 810, Issue 1-2, 1998, Pages 130-137

  Kalichman, Michael W ^a   Dines, Kevin C ^a   Bobik, Marketta ^a   Mizisin, Andrew P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood flow; Hyperglycemia; Peripheral nerve; Rat

Indexed keywords

GALACTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; FEMALE; LASER DOPPLER FLOWMETRY; MOTOR NERVE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SAPHENOUS NERVE; SCIATIC NERVE; SENSORY NERVE; STREPTOZOCIN DIABETES;

ANIMALS; AXONS; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GALACTOSE; HEART RATE; LASER-DOPPLER FLOWMETRY; NERVE FIBERS; NEURAL CONDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE;

EID: 0032501195     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00898-1     Document Type: Article

References (46)

1. Bell M.A., Weddell A.G. A descriptive study of the blood vessels of the sciatic nerve in the rat, man and other mammals. Brain. 107:1984;871-898.
2. Brismar T., Sima A.A. Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: potential clamp analysis. Acta Physiol. Scand. 113(4):1981;499-506.
3. Calcutt N.A., Mizisin A.P., Kalichman M.W. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve. Eur. J. Pharmacol. 251:1994;27-33.
4. Cameron N.E., Cotter M.A., Dines K.C., Maxfield E.K., Carey F., Mirrlees D.J. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose response considerations and independence from a myo-inositol mechanism. Diabetologia. 37:1994;651-663.
5. Cameron N.E., Cotter M.A., Low P.A. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am. J. Physiol. 261:1991;E1-E8.
6. Chang K., Ido Y., LeJeune W., Williamson J.R., Tilton R.G. Increased sciatic nerve blood flow in diabetic rats: assessment by 'molecular' vs. particulate microspheres. Am. J. Physiol. 273(36):1997;E164-E173.
7. de Koning P., Gispen W.H. Org. 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides. 8:1987;415-422.
8. Dines K.C., Mizisin A.P., Jorge M.C., Nunag K.D., Kalichman M.W. Effects of body and hindlimb temperature on laser Doppler blood flow and vascular conductance in rat sciatic nerve and skeletal muscle. J. Neurol. Sci. 148:1997;7-13.
9. Engelstad J.K., Davies J.L., Giannini C., O'Brien P.C., Dyck P.J. No evidence for axonal atrophy in human diabetic polyneuropathy. J. Neuropath. Exp. Neurol. 56(3):1997;255-262.
10. Gabbay K.H., Snider J.J. Nerve conduction defect in galactose fed rats. Diabetes. 21:1972;295-300.
11. Horn S., Quasthoff S., Grafe P., Bostock H., Renner R., Schrank B. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve. 19:1996;1268-1275.
12. Ido Y., Chang K., LeJeune W., Tilton R.G., Monafo W.W., Williamson J.R. Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: Implications for diabetic neuropathy. Am. J. Physiol. 273(36):1997;E174-E184.
13. Jakobsen J. Axonal dwindling in early experimental diabetes: II. A study of isolated nerve fibres. Diabetologia. 12(6):1976;547-553.
14. Jakobsen J. Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats. J. Neurol. Neurosurg. Psychiatry. 42(6):1979;509-518.
15. Julu P.O. The correlation between sensory nerve conduction velocities and three metabolic indices in rats treated with streptozotocin. Diabetologia. 31(4):1988;247-253.
16. Kalichman M.W., Lalonde A.W. Experimental nerve ischemia and injury with cocaine and procaine. Brain Res. 565:1991;34-41.
17. Kalichman M.W., Powell H.C., Calcutt N.A., Mizisin A.P. Mast cell degranulation and blood-nerve barrier permeability in rat sciatic nerve after 7 days of hyperglycemia. Am. J. Physiol. 268:1995;H740-H748.
18. Lambourne J.E., Tomlinson D.R., Brown A.M., Willars G.B. Opposite effects of diabetes and galactosaemia on adenosine triphosphatase activity in rat nervous tissue. Diabetologia. 30(5):1987;360-362.
19. Low P.A., Nukada H., Schmelzer J.D., Tuck R.R., Dyck P.J. Endoneurial oxygen tension and radial topography in nerve oedema. Brain Res. 341:1985;147-154.
20. Low P.A., Tuck R.R. Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J. Physiol. 347:1984;513-523.
21. Mattingly G.E., Fischer V.W. Peripheral nerve axonal dwindling with concomitant myelin sheath hypertrophy in experimentally induced diabetes. Acta Neuropath. 68(2):1985;149-154.
22. McManis P.G., Low P.A., Yao J.K. Relationship between nerve blood flow and intercapillary distance in peripheral nerve edema. Am. J. Physiol. 251:1986;E92-E97.
23. Mizisin A.P., Calcutt N.A., DiStefano P.S., Acheson A., Longo F.M. Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes. 46:1997;647-652.
24. Mizisin A.P., Myers R.R., Powell H.C. Endoneurial sodium accumulation in galactosemic rat nerves. Muscle Nerve. 9:1986;440-444.
25. Myers R.R., Powell H.C. Galactose neuropathy: impact of chronic endoneurial edema on nerve blood flow. Ann. Neurol. 16(5):1984;587-594.
26. Nukada H., Dyck P.J., Low P.A., Lais A.C., Sparks M.F. Axonal caliber and neurofilaments are proportionately decreased in galactose neuropathy. J. Neuropath. Exp. Neurol. 45(2):1986;140-150.
27. Ochodnicka E., Ochdnicky M., Belej K., Fusekova E., Bosel'ova L. Quantitative analysis of myelinated nerve fibers of peripheral nerve in streptozotocin-induced diabetes mellitus. Mol. Chem. Neuropath. 25(2-3):1995;225-233.
28. Sharma A.K., Thomas P.K. Peripheral nerve structure and function in experimental diabetes. J. Neurol. Sci. 23(1):1974;1-15.
29. Sharma A.K., Thomas P.K., De Molina A.F. Peripheral nerve fiber size in experimental diabetes. Diabetes. 26(7):1977;689-692.
30. Sidenius P., Jakobsen J. Axonal transport in early experimental diabetes. Brain Res. 173(2):1979;315-330.
31. Sima A.A.F., Lattimer S.A., Yagihashi S., Greene D.A. Axo-glial dysjunction: a novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J. Clin. Invest. 77:1986;474-484.
32. Stanley E.F. Sensory and motor nerve conduction velocities and the latency of the H reflex during growth of the rat. Exp. Neurol. 71:1981;497-506.
33. Stewart M.A., Sherman W.R., Kurien M.M., Moonsammy G.I., Wisgerhof M. Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosemia. J. Neurochem. 14:1967;1057-1066.
34. Sugimoto H., Monafo W.W., Eliasson S.G. Regional sciatic nerve and muscle blood flow in conscious and anesthetized rats. Am. J. Physiol. 251:1986;H1211-H1216.
35. Takeuchi M., Low P.A. Dynamic peripheral nerve metabolic and vascular responses to exsanguination. Am. J. Physiol. 253:1987;E349-E353.
36. Thomas P.K., Fraher J.P., O'Leary D., Moran M.A., Cole M., King R.H. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat: 2. Effect of streptozotocin-induced diabetes. Acta Neuropathol. 79(4):1990;375-386.
37. Thomas P.K., Jeffreys J.G.R., Sharma A.K., Bajada S. Nerve conduction velocity in experimental diabetes in the rat and rabbit. J. Neurol. Neurosurg. Psychiatry. 44:1981;233-238.
38. Tilton R.G., Chang K., Pugliese G., Eades D.M., Province M.A., Sherman W.R., Kilo C., Williamson J.R. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes. 38:1989;1258-1270.
39. Tomlinson D.R., Holmes P.R., Mayer J.H. Reversal by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci. Lett. 32:1982;189-193.
40. Tuck R.R., Schmelzer J.D., Low P.A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 107(3):1984;935-950.
41. Willars G.B., Calcutt N.A., Tomlinson D.R. Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats. J. Neurol. Sci. 104(1):1991;46-51.
42. Willars G.B., Lambourne J.E., Tomlinson D.R. Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes? Diabetes. 36:1987;1425-1431.
43. Yasuda H., Sonobe M., Yamashita M., Terada M., Hatanaka I., Huitian Z., Shigeta Y. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235. Diabetes. 38(7):1989;832-838.
44. Yue D.K., Hanwell M.A., Satchell P.M., Turtle J.R. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes. 31(9):1982;789-794.
45. Zochodne D.W., Ho L.T. Stimulation induced peripheral nerve hyperemia: mediation by fibers innervating vasa nervorum? Brain Res. 546:1991;113-118.
46. Zochodne D.W., Ho L.T. Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy. Can. J. Physiol. Pharmacol. 70:1992;651-659.